Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Mohn, Kristin G I ^a,b   Cox, Rebecca Jane ^a,b   Tunheim, Gro ^a,c   Berdal, Jan Erik ^d,e,h   Hauge, Ånna Germundsson ^a   Jul Larsen, Asne ^c   Group, Norwegian Pandemic ^c   Peters, Bjoern ^a,c   Oftung, Fredrik ^a   Jonassen, Christine Monceyron ^d,f,g   Mjaaland, Siri ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN VETERINARY INSTITUTE   (Norway)

^f LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^g Østfold Hospital Trust   (Norway)

^h NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; MATRIX PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS HEMAGGLUTININ; VIRUS NUCLEOPROTEIN; VIRUS SIALIDASE; CYTOKINE; EPITOPE; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ACUTE DISEASE; ADULT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MALE; NORWAY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; REVIEW; T LYMPHOCYTE SUBPOPULATION; AGED; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; METABOLISM; MIDDLE AGED; PANDEMIC; SERODIAGNOSIS; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; NORWAY; PANDEMICS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84960155945     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143281     Document Type: Review

References (57)

1. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361: 1935-1944. doi: 10.1056/NEJMoa0906695
2. Louie JK, Gavali S, Acosta M, Samuel MC, Winter K, Jean C et al. (2010) Children hospitalized with 2009 novel influenza A(H1N1) in California. Arch Pediatr Adolesc Med 164: 1023-1031. doi: 10.1001/archpediatrics.2010.203
3. Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B et al. (2010) Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis 10: 145. doi: 10. 1186/1471-2334-10-145
4. Investigators AI, Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M et al. (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361: 1925-1934. doi: 10.1056/NEJMoa0908481
5. NPH NPHDF (2010) The 2009 Influenza Pandemic, surveillance, reports, research. 11.
6. Peiris JS, Tu WW, Yen HL (2009) A novel H1N1 virus causes the first pandemic of the 21st century. Eur J Immunol 39: 2946-2954. doi: 10.1002/eji.200939911
7. Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011) Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July-December 2009. BMC Infect Dis 11: 75. doi: 10.1186/1471-2334-11-75
8. Broadbent AJ, Subbarao K (2011) Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Curr Opin Virol 1: 254-262. doi: 10.1016/j.coviro.2011.08.002
9. Departement DfsobDNPH (2010) Raport New Influenza A(H1N1)pdm09, experiences in Norway. 11, 46-50.
10. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A et al. (2009) Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 302: 1880-1887. doi: 10.1001/jama.2009.1536
11. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A et al. (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-Analysis of individual participant data. Lancet Respir Med 2: 395-404. doi: 10.1016/S2213-2600(14)70041-4
12. Mohn KG-I, Lærum BN, Skrede S, Cox RJ, Dyrhol-Riise AM, Simonsen HE, et al. (2013) Reduced Hospital Stay in Influenza Patients after MassVaccination during the 2009 Influenza Pandemic in Norway. Vaccines & Vaccination 4.
13. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P et al. (2010) Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 5: e9694. doi: 10.1371/journal.pone.0009694
14. Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K et al. (2011) A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 52: 301-312. doi: 10. 1093/cid/ciq152
15. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med 8: e1001053. doi: 10.1371/journal.pmed.1001053
16. Baldanti F, Campanini G, Piralla A, Rovida F, Braschi A, Mojoli F et al. (2011) Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: A multicentre study. Clin Microbiol Infect 17: 1166-1169. doi: 10.1111/j.1469-0691.2010.03403.x
17. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, ChiWet al. (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 27: 797-799. doi: 10.1038/nbt0909-797
18. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: A cross-sectional serological study. Lancet 375: 1100-1108. doi: 10.1016/S0140-6736(09)62126-7
19. Hobson D, Curry RL, Beare AS, Ward-Gardner A (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
20. Kreijtz JH, Fouchier RA, Rimmelzwaan GF (2011) Immune responses to influenza virus infection. Virus Res 162: 19-30. doi: 10.1016/j.virusres.2011.09.022
21. Altenburg AF, Rimmelzwaan GF, de Vries RD (2015) Virus-specific T cells as correlate of (cross-)protective immunity against influenza. Vaccine 33: 500-506. doi: 10.1016/j.vaccine.2014.11.054
22. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, Qin G et al. (2010) Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 84: 6527-6535. doi: 10.1128/JVI.00519-10
23. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370. doi: 10.1073/pnas.0911580106
24. Sridhar S, Begom S, Bermingham A, Ziegler T, Roberts KL, Barclay WS et al. (2012) Predominance of heterosubtypic IFN-gamma-only-secreting effector memory T cells in pandemic H1N1 naive adults. Eur J Immunol 42: 2913-2924. doi: 10.1002/eji.201242504
25. Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A et al. (2015) Natural T Cell Mediated Protection Against Seasonal and Pandemic Influenza: Results of the Flu Watch Cohort Study. Am J Respir Crit Care Med.
26. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, CarmanWet al. (2013) Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 19: 1305-1312. doi: 10. 1038/nm.3350
27. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC et al. (2012) Preexisting influenzaspecific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18: 274-280. doi: 10.1038/nm.2612
28. Zhao Y, Zhang YH, Denney L, Young D, Powell TJ, Peng YC et al. (2012) High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection. Am J Respir Crit Care Med 186: 1292-1297. doi: 10.1164/rccm.201207-1245OC
29. Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N et al. (2014) Characterization of pandemic influenza immune memory signature after vaccination or infection. J Clin Invest 124: 3129-3136. doi: 10.1172/JCI74565
30. Ortiz JR, Rudd KE, Clark DV, Jacob ST, West TE (2013) Clinical research during a public health emergency: A systematic review of severe pandemic influenza management. Crit Care Med 41: 1345-1352. doi: 10.1097/CCM.0b013e3182771386
31. Mohn KG, Bredholt G, Brokstad KA, Pathirana RD, Aarstad HJ, et al. (2014) Longevity of B-Cell and TCell Responses After Live Attenuated Influenza Vaccination in Children. J Infect Dis.
32. WHO (2011) Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Manual.
33. Samdal HH, Bakke H, Oftung F, Holst J, Haugen IL, Korsvold GE et al. (2005) A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants. Hum Vaccin 1: 85-90.
34. Dembinski JL, Hungnes O, Hauge AG, Kristoffersen AC, Haneberg B, Mjaaland S et al. (2014) Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicity. J Virol Methods 207C: 232-237.
35. Pedersen G, Halstensen A, Sjursen H, Naess A, Kristoffersen EK, Cox RJ (2011) Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports. Scand J Immunol 74: 210-218. doi: 10.1111/j.1365-3083.2011.02561.x
36. Savic MD, Dembinski J, Kim Y, Tunheim G, Cox RJ, Oftung F et al (2015) Epitope specific T cell responses against influenza A in a healthy population. Immunology (in press).
37. Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR et al. (2014) The immune epitope database (IEDB) 3.0. Nucleic Acids Res.
38. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, Hugnes O (2010) High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15.
39. Madhun AS, Akselsen PE, Sjursen H, Pedersen G, Svindland S, Nostbakken JK et al. (2010) An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 29: 266-273. doi: 10.1016/j.vaccine.2010.10.038
40. Blasio BF, Iversen BG, Tomba GS (2012) Effect of vaccines and antivirals during the major 2009 A (H1N1) pandemic wave in Norway-And the influence of vaccination timing. PLoS One 7: e30018. doi: 10.1371/journal.pone.0030018
41. Haran JP, Hoaglin DC, Chen H, Boyer EW, Lu S (2014) Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease course. J Clin Virol 60: 367-373. doi: 10.1016/j.jcv.2014.04.017
42. To KK, Hung IF, Li IW, Lee KL, Koo CK, YanWWet al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850-859. doi: 10.1086/650581
43. Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, Fosy J et al. (2011) Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination. PLoS One 6: e28063. doi: 10.1371/journal.pone.0028063
44. Berdal JE, Mollnes TE, Waehre T, Olstad OK, Halvorsen B, Ueland T et al. (2011) Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza. J Infect 63: 308-316. doi: 10.1016/j.jinf.2011.07.004
45. Oughton M, Dascal A, Laporta D, Charest H, Afilalo M and Miller M (2011) Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09. Diagn Microbiol Infect Dis 70: 213-217. doi: 10.1016/j.diagmicrobio.2010.12.013
46. Choi SM, Xie H, Campbell AP, Kuypers J, Leisenring W, Boudrealult AA et al. (2012) Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients. J Infect Dis 206: 1872-1877. doi: 10.1093/infdis/jis610
47. Rykkvin R, Kilander A, Dudman SG, Hungnes O (2013) Within-patient emergence of the influenza A (H1N1)pdm09 HA1 222G variant and clear association with severe disease, Norway. Euro Surveill 18.
48. Bogoch II, Andrews JR, Zachary KC, Hohmann EL (2013) Diagnosis of influenza from lower respiratory tract sampling after negative upper respiratory tract sampling. Virulence 4: 82-84. doi: 10.4161/viru. 22466
49. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P et al. (2009) Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 13: R201. doi: 10.1186/cc8208
50. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911-4927.
51. Guidotti LG, Chisari FV (2000) Cytokine-mediated control of viral infections. Virology 273: 221-227.
52. Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med (Berl) 78: 74-80.
53. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR (2007) Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 81: 8468-8476.
54. Weaver JM, Yang H, Roumanes D, Lee FE, Wu H, Treanor JJ et al. (2013) Increase in IFNgamma(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza. PLoS One 8: e57275. doi: 10.1371/journal.pone.0057275
55. Divekar AA, Zaiss DM, Lee FE, Liu D, Topham DJ, Sijts AJ et al. (2006) Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFNgamma-secreting cells. J Immunol 176: 1465-1473.
56. Yang J, James E, Gates TJ, DeLong JH, LaFond RE, Malhotra U et al. (2013) CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination. Int Immunol 25: 447-457. doi: 10.1093/intimm/dxt005
57. Chiu C, Openshaw PJ (2015) Antiviral B cell and T cell immunity in the lungs. Nat Immunol 16: 18-26. doi: 10.1038/ni.3056